MIN-102 is a selective PPAR gamma agonist with a superior profile for central nervous system related diseases. It has shown robust preclinical proof of concept in multiple animal models. Phase I studi...
Read moreThe fund is driven by ”la Caixa” and the Centro para el Desarrollo Tecnológico Industrial (Centre for Industrial Technological Development, CDTI) under the framework of the Innvierte Programme an...
Read moreLa entrada de ProA Capital, realizada a través de una ampliación de capital, busca potenciar el crecimiento de Suanfarma, tanto de manera orgánica como mediante adquisiciones. El equipo directivo d...
Read moreUn Foro dirigido a inversores y fondos privados, empresas de capital riesgo y entidades del sector salud interesados en apoyar start-ups o proyectos innovadores en fase de comercialización
Read moreThese results demonstrate that alpha therapy can activate an immune response against tumours and produce a lasting anti-tumour protection
Read moreOne of the key strategies to cope with this task is the application of so called screening methods, which are able to deliver a quick analytical result, often at relatively low costs
Read moreEl Fondo de Capital Conocimiento de InKemia entra en el accionariado de la compañía especializada en la industrialización de procesos Biotecnológicos a través de una Ampliación de Capital
Read moreIRB Barcelona receives the support of the ERC to develop a test to predict metastasis of colon and liver cancer
Read moreStudy coordinated by ISGlobal in collaboration with researchers in Papua New Guinea and Australia is published in the Journal of Immunology
Read moreIn the last decade, scientific production in Spanish universities has experienced a rapid increase, as is evident from the 112% increase in the number of publications in scientific journals and 130% g...
Read moreStudy Published in Nature Communications Details Targeted Nanomedicine Therapy to Regenerate Heart Muscle Injured by Heart Attack
Read moreUn equipo de investigadores de Navarrabiomed y de University College London (UCL) ha identificado los mecanismos de envejecimiento del sistema inmune humano y el proceso para reactivarlo
Read more